1,216
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Editorial: themed issue: understanding the technical and social landscape of gene editing

, &

Bibliography

  • Franklin, S. 2013. Biological Relatives: IVF, Stem Cells and the Future of Kinship. Durham, NC: Duke University Press.
  • González Santos, S. P., N. Stephens, and R. Dimond. 2018. “Narrating the First ‘Three-Parent Baby’: The Initial Press Reactions from the United Kingdom, the United States, and Mexico.” Science Communication 40 (4): 419–441.
  • Haddow, G., A. Bruce, J. Calvert, S. H. Harmon, and W. Marsden. 2010. “Not ‘Human’ Enough to be Human But Not “Animal” Enough to be Animal – The Case of the HFEA, Cybrids and Xenotransplantation in the UK.” New Genetics and Society 29 (1): 3–17.
  • Hedgecoe, A., and R. Tutton. 2018. “Editorial.” New Genetics and Society 37 (1): 1.
  • Jasanoff, S., J. B. Hurlbut, and K. Saha. 2019. “Democratic Governance of Human Germline Genome Editing.” The CRISPR journal 2 (5): 266–271.
  • Keating, P., and A. Cambrosio. 2000. “Biomedical platforms.” Configurations 8 (3): 337–387.
  • Ledford, H. 2020. “Quest to Use Crispr Against Disease Gains Ground.” Nature 577 (7789): 156–157.
  • Liaw, Y. Q., I. Turkmendag, and K. Hollingsworth. 2021. Reinterpreting ‘genetic identity’ in the regulatory and ethical context of heritable genome editing. New Genetics and Society [Online First].
  • Martin, P., M. Morrison, I. Turkmendag, B. Nerlich, A. McMahon, S. de Saille, and A. Bartlett. 2020. “Genome Editing: The Dynamics of Continuity, Convergence, and Change in the Engineering of Life.” New Genetics and Society 39 (2): 219–242.
  • Martin, P. A., and I. Turkmendag. 2021. Thinking the unthinkable: how did human germline genome editing become ethically acceptable?. New Genetics and Society [Online First].
  • Mulvihill, J. J., B. Capps, Y. Joly, T. Lysaght, H. A. Zwart, and R. Chadwick. 2017. the International Human Genome Organisation (HUGO) Committee of Ethics, Law, and Society (CELS) “Ethical Issues of CRISPR Technology and Gene Editing Through the Lens of Solidarity.” British Medical Bulletin 122 (1): 17–29.
  • Parry, S. 2003. “The Politics of Cloning: Mapping the Rhetorical Convergence of Embryos and Stem Cells in Parliamentary Debates.” New Genetics and Society 22 (2): 177–200.
  • Ranisch, R., and H. J. Ehni. 2020. “Fading Red Lines? Bioethics of Germline Genome Editing.” Bioethics 34 (1): 3–6.
  • Scott, C. 2015. “Treading the Line Between Sensational and Ground-Breaking Science.” The American Journal of Bioethics 15 (12): 1–2.
  • Sleeboom-Faulkner, M. 2011. “Regulating Cell Lives in Japan: Avoiding Scandal and Sticking to Nature.” New Genetics and Society 30 (3): 227–240.
  • So, D., R. Sladek, and Y. Joly. 2021. “Assessing Public Opinions on the Likelihood and Permissibility of Gene Editing Through Construal Level Theory.” New Genetics and Society [Online First].
  • Wahlberg, A., D. Dong, P. Song, and Z. Jianfeng. 2021. The platforming of human embryo editing: prospecting ‘disease free’ futures. New Genetics and Society [Online First].
  • WHO. 2021. Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. Human Genome Editing: Recommendations. Geneva: World Health Organization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.